Christoph Huber
Chief Executive Officer bei tonestro
Profil
Christoph Huber was the founder of Ganymed Pharmaceuticals AG, founded in 2001, where he held the title of Vice Chairman-Supervisory Board.
He was also the founder of BioNTech SE, founded in 2008, where he held the title of Member-Supervisory Board until 2023.
Currently, Dr. Huber holds multiple positions, including Chairman at Association For Cancer Immunotherapy, Deputy Chairman-Supervisory Board at Tirol Kliniken GmbH, Director at Ci3 Management UG, Member-Supervisory Board at AFFiRiS AG since 2015, and Advisory Board at Onsight Ventures Management GmbH.
Dr. Huber's former positions include Chairman-Hematology & Oncology Department at The Johannes Gutenberg University of Mainz and Member-Supervisory Board at TRON - Translationale Onkologie an der Universitätsmedizin der from 2018 to 2019.
Dr. Huber received his doctorate degree from the University of Innsbruck.
Dr. Huber is also the founder of tonestro.
Aktive Positionen von Christoph Huber
| Unternehmen | Position | Beginn |
|---|---|---|
| Association For Cancer Immunotherapy | Chairman | - |
| Ci3 Management UG | Director/Board Member | - |
AFFiRiS AG
 AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Director/Board Member | 18.05.2015 |
| Tirol Kliniken GmbH | Director/Board Member | - |
tonestro
 tonestro Packaged SoftwareTechnology Services Tonestro is a music app that provides wind instrument lessons for individuals to learn and practice at home. The company is based in Pierbach, Austria. The app offers live feedback on rhythm and pitch while listening to the user play their instrument. The Austrian company was founded by Alexander Kogler, Christian Kapplmüller, Heinrich Huber, Christoph Huber, with Christoph Huber serving as CEO since its inception. | Chief Executive Officer | - |
Onsight Ventures
 Onsight Ventures Investment ManagersFinance Onsight Ventures Management GmbH (Onsight Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Innsbruck, Austria. | Consultant / Advisor | - |
Ehemalige bekannte Positionen von Christoph Huber
| Unternehmen | Position | Ende |
|---|---|---|
| BIONTECH SE | Founder | 25.05.2023 |
TRON - Translationale Onkologie an der Universitätsmedizin der
 TRON - Translationale Onkologie an der Universitätsmedizin der Miscellaneous Commercial ServicesCommercial Services TRON - Translationale Onkologie an der Universitätsmedizin der is an independent biopharmaceutical non-profit translational research organization located in Mainz, Germany. TRON pursues new diagnostics and drugs for the treatment of cancer and other diseases with high medical need through their PhD Program. The German company was founded in 2010 by Ugur Sahin and the CEO is Michael Föhlings. | Director/Board Member | 01.04.2019 |
| The Johannes Gutenberg University of Mainz | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░ | - |
Ausbildung von Christoph Huber
| University of Innsbruck | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIONTECH SE | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Ganymed Pharmaceuticals AG
 Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services AFFiRiS AG develops and produces vaccines for therapeutic treatment of chronic diseases. It provides research services and develops vaccines based on peptide antigens applied in the fields of biochemistry, molecular and cell biology, immunology and veterinary medicine. AFFiRiS was founded by Walter Schmidt and Frank Mattner in November 2003 and is headquartered in Vienna, Austria. | Health Services |
| Association For Cancer Immunotherapy | |
| Ci3 Management UG | |
TRON - Translationale Onkologie an der Universitätsmedizin der
TRON - Translationale Onkologie an der Universitätsmedizin der Miscellaneous Commercial ServicesCommercial Services TRON - Translationale Onkologie an der Universitätsmedizin der is an independent biopharmaceutical non-profit translational research organization located in Mainz, Germany. TRON pursues new diagnostics and drugs for the treatment of cancer and other diseases with high medical need through their PhD Program. The German company was founded in 2010 by Ugur Sahin and the CEO is Michael Föhlings. | Commercial Services |
| Tirol Kliniken GmbH | |
tonestro
tonestro Packaged SoftwareTechnology Services Tonestro is a music app that provides wind instrument lessons for individuals to learn and practice at home. The company is based in Pierbach, Austria. The app offers live feedback on rhythm and pitch while listening to the user play their instrument. The Austrian company was founded by Alexander Kogler, Christian Kapplmüller, Heinrich Huber, Christoph Huber, with Christoph Huber serving as CEO since its inception. | Technology Services |
Onsight Ventures
Onsight Ventures Investment ManagersFinance Onsight Ventures Management GmbH (Onsight Ventures) is a venture capital firm founded in 2021. The firm is headquartered in Innsbruck, Austria. | Finance |
